Articles from Gilead Sciences, Inc. and Arcellx, Inc.

Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma

Kite, a Gilead Company (NASDAQGILD), and Arcellx, Inc. NASDAQ: ACLXNASDAQACLX)

By Gilead Sciences, Inc. and Arcellx, Inc. · Via Business Wire · January 30, 2023